UK Dementia Research Institute launches major new cellular model platform

From the UK Dementia Research Institute

Reading Time: < 1 minute

The UK Dementia Research Institute (UKDRI) is thrilled to announce a major new initiative to explore risk factors that contribute to the development of Alzheimer’s disease. Led by Prof Julie Williams, Centre Director from UK DRI at Cardiff, the new platform – called the IPSC Platform to Model Alzheimer’s Disease Risk (IPMAR) – aims to become one of the largest cellular model resources available to study the condition, accessible to researchers across the world.

This programme is the third awarded in our series of Directors’ Strategic Initiatives from the UK DRI, joining the Gene Therapy Platform (UK DRI at King’s) and the Multi-‘omics Atlas Project (UK DRI at Imperial).

For full details visit the UK Dementia Research Institute Website

Leave a Reply


he UK DRI breaks new ground by bringing together world-leading expertise in biomedical, care and translational dementia research in a national institute currently made up of over 600 researchers and a support team of over 50, all growing rapidly.

The institute carries out research relevant to all dementias, including Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia, vascular dementia, Huntington’s disease and beyond.

Enjoy listening to our podcasts?

We need your help – please vote for Dementia Researcher in the People’s Choice Podcast Awards.

  1. Click the link below
  2. Register
  3. Find us in the Science & Medicine Category
  4. Hit submit

Cast your vote here
I already voted – close this box

Translate »